Mohamed A. Eldeeb

1.1k total citations · 1 hit paper
45 papers, 750 citations indexed

About

Mohamed A. Eldeeb is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Mohamed A. Eldeeb has authored 45 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Mohamed A. Eldeeb's work include Ubiquitin and proteasome pathways (18 papers), Autophagy in Disease and Therapy (14 papers) and Protein Degradation and Inhibitors (9 papers). Mohamed A. Eldeeb is often cited by papers focused on Ubiquitin and proteasome pathways (18 papers), Autophagy in Disease and Therapy (14 papers) and Protein Degradation and Inhibitors (9 papers). Mohamed A. Eldeeb collaborates with scholars based in Canada, Egypt and United States. Mohamed A. Eldeeb's co-authors include Mohamed A. Ragheb, Richard P. Fahlman, Edward A. Fon, Rhalena A. Thomas, Mansoore Esmaili, Jean‐François Trempe, Cornelia E. Zorca, Thomas Goiran, Shafqat Rasool and Naoto Soya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Physiological Reviews.

In The Last Decade

Mohamed A. Eldeeb

42 papers receiving 744 citations

Hit Papers

Mitochondrial quality control in health and in Parkinson’... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed A. Eldeeb Canada 16 489 234 171 103 97 45 750
Silvia Nerini‐Molteni Italy 10 282 0.6× 217 0.9× 115 0.7× 68 0.7× 130 1.3× 13 643
Ryo Yonashiro Japan 8 694 1.4× 234 1.0× 57 0.3× 57 0.6× 109 1.1× 8 841
Laura Ciarlo Italy 18 454 0.9× 171 0.7× 53 0.3× 76 0.7× 150 1.5× 21 824
Esti Liani Israel 9 360 0.7× 228 1.0× 313 1.8× 61 0.6× 111 1.1× 10 730
Soung Jung Kim South Korea 14 400 0.8× 116 0.5× 59 0.3× 50 0.5× 49 0.5× 16 637
Esther Seco Spain 6 457 0.9× 347 1.5× 43 0.3× 62 0.6× 78 0.8× 7 695
Emiliano Maiani Italy 13 370 0.8× 108 0.5× 59 0.3× 45 0.4× 54 0.6× 19 654
Pablo Sánchez‐Martín Germany 10 389 0.8× 372 1.6× 61 0.4× 41 0.4× 135 1.4× 15 672
Nobuko Matsushita Japan 10 599 1.2× 216 0.9× 46 0.3× 46 0.4× 156 1.6× 12 808

Countries citing papers authored by Mohamed A. Eldeeb

Since Specialization
Citations

This map shows the geographic impact of Mohamed A. Eldeeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed A. Eldeeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed A. Eldeeb more than expected).

Fields of papers citing papers by Mohamed A. Eldeeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed A. Eldeeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed A. Eldeeb. The network helps show where Mohamed A. Eldeeb may publish in the future.

Co-authorship network of co-authors of Mohamed A. Eldeeb

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed A. Eldeeb. A scholar is included among the top collaborators of Mohamed A. Eldeeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed A. Eldeeb. Mohamed A. Eldeeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ragheb, Mohamed A., et al.. (2025). Folic acid-modified chitosan nanoparticles for targeted delivery of a binuclear Co(II) complex in cancer therapy. International Journal of Biological Macromolecules. 311(Pt 4). 144034–144034. 3 indexed citations
2.
Barghout, Samir H. & Mohamed A. Eldeeb. (2025). Emerging pharmacology of targeted protein degraders. Journal of Pharmacology and Experimental Therapeutics. 392(12). 103694–103694.
3.
Eldeeb, Mohamed A., Andrew N. Bayne, Thomas Goiran, et al.. (2024). Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress. Proceedings of the National Academy of Sciences. 121(10). e2313540121–e2313540121. 36 indexed citations
4.
Eldeeb, Mohamed A., et al.. (2024). Targeted degradation of membrane proteins. Nature Structural & Molecular Biology. 32(1). 2–4. 1 indexed citations
5.
Eldeeb, Mohamed A., et al.. (2023). How does mitochondrial import machinery fine-tune mitophagy? Different paths and one destination. Trends in Endocrinology and Metabolism. 34(8). 427–429. 3 indexed citations
6.
Croteau, Nathalie, Mohamed A. Eldeeb, Odetta Antico, et al.. (2023). Structure-based design and characterization of Parkin-activating mutations. Life Science Alliance. 6(6). e202201419–e202201419. 24 indexed citations
7.
Eldeeb, Mohamed A., et al.. (2022). A molecular dialogue between local translation and mitochondria: powering mitophagy in axons. Molecular Biology Reports. 49(9). 9013–9016. 1 indexed citations
8.
Eldeeb, Mohamed A., et al.. (2022). Dephosphorylation Targeting Chimaera (DEPTAC): Targeting Tau Proteinsin Tauopathies. Current Protein and Peptide Science. 23(3). 129–132. 2 indexed citations
9.
Eldeeb, Mohamed A., et al.. (2022). Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways. Neurotoxicity Research. 40(1). 298–318. 5 indexed citations
10.
Eldeeb, Mohamed A., Mansoore Esmaili, Marwa Hassan, & Mohamed A. Ragheb. (2022). The Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy. Neurotoxicity Research. 40(4). 1103–1114. 18 indexed citations
11.
Rasool, Shafqat, Simon Veyron, Naoto Soya, et al.. (2021). Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex. Molecular Cell. 82(1). 44–59.e6. 71 indexed citations
12.
Eldeeb, Mohamed A. & Mohamed A. Ragheb. (2020). N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase. Current Genetics. 66(4). 693–701. 27 indexed citations
13.
Hussain, Faraz, Mohamed A. Eldeeb, Derrick Blackmore, & Zaeem A. Siddiqi. (2020). Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm. Autoimmunity Reviews. 19(12). 102681–102681. 25 indexed citations
14.
Eldeeb, Mohamed A., Cornelia E. Zorca, & Thomas Goiran. (2020). Extracellular protein degradation via the lysosome. Communications Chemistry. 3(1). 149–149. 12 indexed citations
15.
Fava, Vinicius M., Guillaume Lettre, Nguyen Van Thuc, et al.. (2019). Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease. Proceedings of the National Academy of Sciences. 116(31). 15616–15624. 41 indexed citations
16.
Eldeeb, Mohamed A., Richard P. Fahlman, Mansoore Esmaili, & Edward A. Fon. (2019). When Degradation Elicits the Alarm: N-Terminal Degradation of NLRP1B Unleashes Its Inflammasome Activity. Molecular Cell. 74(4). 637–639. 6 indexed citations
17.
Eldeeb, Mohamed A., et al.. (2019). Beyond ER: Regulating TOM-Complex-Mediated Import by Ubx2. Trends in Cell Biology. 29(9). 687–689. 9 indexed citations
18.
Eldeeb, Mohamed A., Mansoore Esmaili, & Richard P. Fahlman. (2019). Degradation of proteins with N-terminal glycine. Nature Structural & Molecular Biology. 26(9). 761–763. 11 indexed citations
19.
Eldeeb, Mohamed A.. (2017). Aging: when the ubiquitin–proteasome machinery collapses. SHILAP Revista de lepidopterología. 4(2). 219–223. 1 indexed citations
20.
AlMatar, Manaf, et al.. (2016). Are There Any Other Compounds Isolated From Dermacoccus spp at All?. Current Microbiology. 74(1). 132–144. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026